← Leaderboard
NVO
Ticker
NVO
Congressional Trades
46
by 10 members
Ticker Intelligence Brief
Who in Congress traded NVO, when, and what happened after?
A ticker-first view for retail/data users: latest disclosure, largest range, disclosure lag, party flow, contracts, lobbying, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-03-13
Largest range
$100K – $250K
Michael McCaul
Slowest filing
318d
Valerie Hoyle
Best vs SPY
6.8%
Ro Khanna
Buys
23
50%
Sells
22
48%
Total Volume
$1.1M
midpoint
Unique Traders
10
members
Party Breakdown
Democrats5 · 11%
Republicans41 · 89%
Party Trading Divergence
Democrat vs. Republican buy / sell pressure by monthALIGNEDBar length = total trades. Color = net sentiment — green = net buying, red = net selling. Months with no activity hidden.
Democrat ←
Month
→ Republican
—
Jan '24
0▲1▼
0▲1▼
Feb '24
—
—
Apr '24
3▲
—
May '24
3▲
0▲1▼
Jul '24
—
—
Aug '24
1▲1▼
—
Sep '24
0▲1▼
1▲
Oct '24
—
—
Nov '24
0▲2▼
—
Mar '25
2▲1▼
—
May '25
1▲3▼
—
Jun '25
2▲2▼
—
Jul '25
0▲3▼
—
Aug '25
4▲2▼
—
Sep '25
2▲
—
Oct '25
2▲4▼
1▲
Feb '26
—
1▲
Mar '26
—
Democrats3▲2▼Net buyers
vs
Republicans20▲20▼Neutral
Net buyingNet selling⚡ Party split
💼 Lobbying Filings
all →- 2026-04-22$10KNOVO NORDISK INC.
- 2026-04-20$1.3MNOVO NORDISK INC.Obesity, Treat and Reduce Obesity Act, Insulin Pricing/affordability, IRA implementation and drug pricing legislation, supply chain, 340B, Intellectual Property/patent protection, S. 150 - the Affordable Prescriptions for Patients Act, Protect 340B Act, PBM Reform Act, General Compounding Labor-HHS Appropriations Bill, Military Construction, Treat and Reduce Obesity Act, General Compounding, FDA Agricultural Appropriations bill Obesity, Treat and Reduce Obesity Act, IRA implementation, General engagement around drug pricing S. 150, Affordable Prescriptions for Patients Act, Patent Protection, General IP Issues, General Compounding International and corporate tax issues Tariffs and trade policy
- 2026-04-20$80KNOVO NORDISK INC.Issues related to compounding and counterfeit drugs. Issues related to drug pricing and implementation of the Inflation Reduction Act. H.R. 1492, the Ensuring Pathways to Innovative Cures Act. Issues related to coverage of anti-obesity medications. Issues related to pharmacy benefit management reforms. Issues related to Most Favored Nation drug pricing. Monitored issues related to the implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes and foreign-based multinationals. Monitor OECD negotiations on the Pillar II global minimum tax. Issues related to tariffs. Issues related to importation of counterfeit drugs.
- 2026-04-20$80KNOVO NORDISK INC.Issues related to Medicare coverage of Anti-Obesity Medicines. Issues related to pharmaceutical supply chain transparency and integrity. Issues related to compounding and counterfeit medicines.
- 2026-04-20$60KNOVO NORDISK INC.Medication affordability and access; general diabetes prevention, 340B, monitoring FDA reform, changes and new programs. Support for obesity drug coverage and access. Treat and Reduce Obesity Act; Medication affordability and access; general diabetes prevention; "Inflation Reduction Act of 2022" (PL 117-169) implementation. Pharmacy benefit manager reform proposals. H.R. 1, One Big Beautiful Bill Act, issues related to biopharmaceutical issues Prescription drug pricing issues, particularly related to MFN. Issues related to corporate tax and international tax including related domestic and international tax issues for reconciliation legislation; monitor implementation of PL 119-21. General issues related to patent protections.
- 2026-04-20$60KNOVO NORDISK INC.Implementation of Inflation Reduction Act. Pharmacy Benefit Manager Reform. Health care supply chain. 340B. Treat and Reduce Obesity Act.
- 2026-04-20$60KNOVO NORDISK INC.IRA, medication affordability and access, general diabetes prevention, obesity, impacts of drug shortages, drug supply chain Treat and Reduce Obesity Act, obesity treatment Federal budget issues
- 2026-04-20$20KNOVO NORDISK INC.Issues related to obesity; Issues related to medication affordability and access
- 2026-04-17$80KNOVO NORDISK INC.Issues related to general compounding. Issues related to the clinical and overall benefit of anti-obesity medications. Issues related to insulin pricing/affordability. Issues related to general compounding. Issues related to CMS coverage of anti-obesity medications, including the Treat and Reduce Obesity Act of 2025 (H.R. 4231 / S. 1973). Issues related to general compounding.
- 2026-04-17$20KNOVO NORDISK INC.Issues related to compounding and counterfeit drugs. Issues related to drug pricing and implementation of the Inflation Reduction Act; coverage of anti-obesity medications; pharmacy benefit management reforms; Most Favored Nation drug pricing. Issues related to tariffs and importation of counterfeit drugs.
Congressional Momentum
buy vs. sell pressureACCUMULATINGScore 0–100: above 50 = net buying pressure, below 50 = net selling. Signal based on last 90 days.
Last 30 Days
No trades
Last 90 Days
No trades
All-Time
▲59
23 buys46 total23 sells
$651K buys · $459K sells
Cumulative Net Position (buy vol − sell vol)
+$192K
2019-0346 trades plotted2026-03
Best Timers
avg excess return vs SPY · NVO trades only8 members w/ alpha dataExcess return = stock price change minus SPY change over the same holding window.Congress avg: -70.7%· 0% of traders beat SPY on this name
Top Alpha Generators
D:2R:6House:8
underperformed SPY|beat SPY
Worst Timers
bottom 5 by avg excess return
underperformed SPY|beat SPY
Worst single trade: Michael McCaul (-110.2%)Best single trade: Ro Khanna (+6.8%)
Timing Fingerprint
filing delay vs. excess return over SPY · 32 tradesCongress avg -68.9% vs SPYEach dot = one disclosed trade. X-axis = days between trade and STOCK Act filing.Y-axis = return above (or below) SPY over the subsequent holding window. Upper-right = late filers who beat the market.
3% of trades beat SPYavg excess -68.9%avg delay 33d17 buys15 sellsBuySellOther· dot size ∝ trade size
Congress Swarm Events
synchronized trading — 3+ members within 21 daysSUSPICIOUSA swarm event occurs when 3 or more members disclose trades in NVO within a rolling 21-day window. Tight windows with high directional consensus score highest on the suspicion meter.
🔴 #1MIXED3 members · 5d span
60
Window
2025-07-30 → 2025-08-04
▲ 4 buys▼ 3 sells$172K vol
Consensus
57%
RMichael McCaul2025-07-30
RLisa McClain2025-08-042×
RC. Franklin2025-08-044×
1 swarm event detectedmax members in single event: 3highest suspicion score: 6021-day rolling window · top 6 by score
Trade Activity Timeline
Congressional buys & sells by month · last 19 months w/ activity
19/03
24/01
24/02
24/04
24/05
24/07
24/08
24/09
24/10
24/11
25/03
25/05
25/06
25/07
25/08
25/09
25/10
26/02
26/03
BuysSellsOtherHigh-volume month
Who Moved First
each row = one member · sorted by earliest disclosed trade6 buyers ·8 sellers
BuySellOtherDot size ∝ trade size · top 10 most-active traders shown
Seasonal Rhythm
Congress buy/sell pressure by month & yearEach cell = one calendar month. Green = net Congress buying, red = net selling. Intensity ∝ consensus strength. Hover for details.
Net buyingNet sellingNo trades · number = trade count
Peak buy month: Aug · Peak sell month: Jul
Congressional Conviction Timeline
net positioning · alpha track recordMIXED23 buys23 sellscumulative α -1190.7%19mo tracked
Monthly Net Flow (Buys − Sells)
Cumulative Excess Return on Congressional Buys vs SPY
All Disclosed Trades
| Date | Member | Action | Amount | Filing Delay | Receipt |
|---|---|---|---|---|---|
| 2026-03-13 | DRo Khanna | BUY | $1K – $15K | 25d | receipt → |
| 2026-02-13 | DRo Khanna | BUY | $1K – $15K | 24d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 24d | receipt → |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 25d | receipt → |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 25d | receipt → |
| 2025-10-31 | RLisa McClain | SELL | $1K – $15K | 21d | receipt → |
| 2025-10-30 | RLisa McClain | BUY | $1K – $15K | 22d | receipt → |
| 2025-10-30 | RLisa McClain | SELL | $1K – $15K | 22d | receipt → |
| 2025-09-11 | RLisa McClain | BUY | $1K – $15K | 42d | receipt → |
| 2025-09-11 | RLisa McClain | BUY | $1K – $15K | 41d | receipt → |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 42d | receipt → |
| 2025-08-04 | RLisa McClain | SELL | $1K – $15K | 39d | receipt → |
| 2024-10-29 | DValerie Hoyle | BUY | $1K – $15K | 318d | receipt → |
| 2025-08-04 | RC. Franklin | BUY | $15K – $50K | 11d | receipt → |
| 2025-08-04 | RC. Franklin | BUY | $1K – $15K | 11d | receipt → |
| 2025-07-10 | RLisa McClain | SELL | $1K – $15K | 35d | receipt → |
| 2025-06-09 | RLisa McClain | BUY | $1K – $15K | 66d | receipt → |
| 2025-08-04 | RC. Franklin | BUY | $1K – $15K | 10d | receipt → |
| 2025-08-04 | RC. Franklin | BUY | $15K – $50K | 10d | receipt → |
| 2025-07-30 | RMichael McCaul | SELL | $50K – $100K | 14d | receipt → |
| 2025-07-10 | RLisa McClain | SELL | $1K – $15K | 34d | receipt → |
| 2025-06-09 | RLisa McClain | BUY | $1K – $15K | 65d | receipt → |
| 2025-06-27 | RMichael McCaul | SELL | $50K – $100K | 10d | receipt → |
| 2025-06-16 | RMichael McCaul | SELL | $15K – $50K | 21d | receipt → |
| 2025-05-08 | RLaurel Lee | SELL | $1K – $15K | 46d | receipt → |
| 2025-05-08 | RLaurel Lee | SELL | $1K – $15K | 45d | receipt → |
| 2025-05-08 | RLaurel Lee | PARTIAL_SELL | $1K – $15K | 27d | receipt → |
| 2025-05-08 | RLaurel Lee | BUY | $2K – $2K | 27d | receipt → |
| 2025-03-20 | RByron Donalds | SELL | $1K – $15K | 25d | receipt → |
| 2025-03-27 | RC. Franklin | BUY | $1K – $15K | 15d | receipt → |
| 2025-03-27 | RC. Franklin | BUY | $15K – $50K | 15d | receipt → |
| 2024-11-19 | RMichael McCaul | SELL | $50K – $100K | 27d | receipt → |
| 2024-11-19 | RMichael McCaul | SELL | $15K – $50K | 27d | receipt → |
| 2024-08-26 | RMichael McCaul | SELL | $1K – $15K | 21d | receipt → |
| 2024-08-09 | RMichael McCaul | BUY | $15K – $50K | 38d | receipt → |
| 2024-09-04 | RJohn James | SELL | $1K – $15K | 2d | receipt → |
| 2024-07-12 | DRo Khanna | SELL | $1K – $15K | 26d | receipt → |
| 2024-05-29 | RMichael McCaul | BUY | $15K – $50K | 15d | receipt → |
| 2024-05-28 | RMichael McCaul | BUY | $15K – $50K | 16d | receipt → |
| 2024-05-06 | RMichael McCaul | BUY | $15K – $50K | 38d | receipt → |
| 2024-04-24 | RMichael McCaul | BUY | $50K – $100K | 17d | receipt → |
| 2024-04-23 | RMichael McCaul | BUY | $100K – $250K | 18d | receipt → |
| 2024-04-23 | RMichael McCaul | BUY | $50K – $100K | 18d | receipt → |
| 2024-02-09 | DRo Khanna | SELL | $1K – $15K | 26d | receipt → |
| 2024-01-19 | RTommy Tuberville | SELL | $15K – $50K | 27d | receipt → |
| 2019-03-11 | RShelley Capito | SELL | $1K – $15K | 1631d | receipt → |